- Home
- M vs FOLD Comparison
M vs FOLD Comparison
Compare M & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- M
- FOLD
- Stock Information
- Founded
- M 1830
- FOLD 2002
- Country
- M United States
- FOLD United States
- Employees
- M N/A
- FOLD N/A
- Industry
- M Department/Specialty Retail Stores
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- M Consumer Discretionary
- FOLD Health Care
- Exchange
- M Nasdaq
- FOLD Nasdaq
- Market Cap
- M 3.2B
- FOLD 2.9B
- IPO Year
- M N/A
- FOLD 2007
- Fundamental
- Price
- M $11.63
- FOLD $5.98
- Analyst Decision
- M Hold
- FOLD Buy
- Analyst Count
- M 11
- FOLD 10
- Target Price
- M $14.10
- FOLD $16.22
- AVG Volume (30 Days)
- M 5.6M
- FOLD 4.9M
- Earning Date
- M 05-20-2025
- FOLD 05-01-2025
- Dividend Yield
- M 6.28%
- FOLD N/A
- EPS Growth
- M 1193.75
- FOLD N/A
- EPS
- M 2.07
- FOLD N/A
- Revenue
- M $23,006,000,000.00
- FOLD $543,141,000.00
- Revenue This Year
- M N/A
- FOLD $21.87
- Revenue Next Year
- M N/A
- FOLD $22.19
- P/E Ratio
- M $5.62
- FOLD N/A
- Revenue Growth
- M N/A
- FOLD 28.25
- 52 Week Low
- M $9.76
- FOLD $6.20
- 52 Week High
- M $20.70
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- M 48.18
- FOLD 28.44
- Support Level
- M $11.47
- FOLD $5.82
- Resistance Level
- M $12.00
- FOLD $7.71
- Average True Range (ATR)
- M 0.35
- FOLD 0.31
- MACD
- M 0.14
- FOLD -0.06
- Stochastic Oscillator
- M 68.18
- FOLD 8.47
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's nameplate, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's nameplates, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.